OpenAI 收购 Orchestra Bio，扩展 Rosalind 生命科学模型与工具
OpenAI 宣布收购 Orchestra Bio，该平台帮助生物制药团队协调复杂的药物研发流程。OpenAI 表示将在面向生命科学研究的 Rosalind 模型与工具基础上整合该平台，以简化相关运营流程、让新疗法更快惠及患者，并欢迎 @ashokaraj_ 及其团队加入。Testing Catalog 指出，生命科学是 Anthropic、OpenAI 和 Google 共同的重点方向。
🚨 AI News | TestingCatalog· @testingcatalog · X·2026-10-21 02:21· 21 分钟前AI 评分62
AI 导读
OpenAI 宣布收购 Orchestra Bio，一个帮助生物制药团队协调复杂药物研发流程的平台。OpenAI 表示将在 Rosalind 生命科学研究模型与工具基础上整合该平台，帮助新疗法更快惠及患者；作者指出生命科学是 Anthropic、OpenAI 和 Google 共同的重点方向。
正文 · 原文
OpenAI ❤️ Orchestra Bio
OpenAI has acquired Orchestra Bio to work on Rosalind models and tools for life sciences research.
"Orchestra Bio is a platform that helps biopharma teams coordinate the complex process of drug development."
AI advancements in life sciences are probably one of the most desired areas for many. So far, it seems like a top priority for Anthropic, OpenAI, and Google.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/在 X 查看被引用的帖子
来源：🚨 AI News | TestingCatalog · x.com
来源：RadarAI · aihot.news